Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Gender-Affirming Testosterone Therapy on Drug Metabolism, Transport, and Gut Microbiota

NCT05116293 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05116293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05116293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Gender-Affirming Testosterone Therapy on Drug Metabolism, Transport, and Gut Microbiota
Lead sponsor
University of Washington
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
December 31, 2025
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transgender persons